Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Prestige Consumer Healthcare (PBH)
NYSE:PBH
RESEARCH TOOLSreports
Holding PBH?
Track your performance easily
PBH Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$57.95 - $86.36
Previous Close$82.3
Volume210.92K
Average Volume (3M)267.29K
Market Cap
$4.07B
Enterprise Value$5.08B
Total Cash (Recent Filing)$51.54M
Total Debt (Recent Filing)$1.06B
Price to Earnings (P/E)20.0
Beta0.40
Next Earnings
Feb 06, 2025EPS Estimate
$1.16Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)4.11
Shares Outstanding49,405,454
10 Day Avg. Volume259,129
30 Day Avg. Volume267,293
Standard Deviation0.07
R-Squared0.13
Alpha0.00994
Financial Highlights & Ratios
Price to Book (P/B)2.35
Price to Sales (P/S)3.66
Price to Cash Flow (P/CF)14.60
P/FCF Ratio14.30
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.57
Enterprise Value/Gross Profit8.13
Enterprise Value/Ebitda-437.23
Forecast
1Y Price Target
$86.33Price Target Upside5.29% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering4
Prestige Consumer Healthcare News
PremiumCompany Announcements
Prestige Consumer Healthcare Reports Robust Q2 FY25 Results
PremiumCompany Announcements
Prestige Consumer Healthcare Exceeds Q2 2025 Expectations
Ownership Overview
1.14% Insiders
43.19% Mutual Funds
22.28% Other Institutional Investors
5.13% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
PBH FAQ
What was Prestige Consumer Healthcare’s price range in the past 12 months?
Prestige Consumer Healthcare lowest stock price was $57.95 and its highest was $86.36 in the past 12 months.
What is Prestige Consumer Healthcare’s market cap?
Currently, no data Available
When is Prestige Consumer Healthcare’s upcoming earnings report date?
Prestige Consumer Healthcare’s upcoming earnings report date is Feb 06, 2025 which is in 46 days.
How were Prestige Consumer Healthcare’s earnings last quarter?
Prestige Consumer Healthcare released its earnings results on Nov 07, 2024. The company reported $1.09 earnings per share for the quarter, beating the consensus estimate of $1.085 by $0.005.
Is Prestige Consumer Healthcare overvalued?
According to Wall Street analysts Prestige Consumer Healthcare’s price is currently Undervalued.
Does Prestige Consumer Healthcare pay dividends?
Prestige Consumer Healthcare does not currently pay dividends.
What is Prestige Consumer Healthcare’s EPS estimate?
Prestige Consumer Healthcare’s EPS estimate is $1.16.
How many shares outstanding does Prestige Consumer Healthcare have?
Prestige Consumer Healthcare has 49,405,453 shares outstanding.
What happened to Prestige Consumer Healthcare’s price movement after its last earnings report?
Prestige Consumer Healthcare reported an EPS of $1.09 in its last earnings report, beating expectations of $1.085. Following the earnings report the stock price went up 3.156%.
Which hedge fund is a major shareholder of Prestige Consumer Healthcare?
Among the largest hedge funds holding Prestige Consumer Healthcare’s share is Ariel Investments LLC. It holds Prestige Consumer Healthcare’s shares valued at 201M.
---
Prestige Consumer Healthcare Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$86.33 (5.29% Upside)
$86.33 (5.29% Upside)
Blogger Sentiment
Bullish
PBH Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 8.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $12.0M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
35.85%
12-Months-Change
Fundamentals
Return on Equity
12.61%
Trailing 12-Months
Asset Growth
-0.48%
Trailing 12-Months
Company Description
Prestige Consumer Healthcare
Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. It operates through the following segments: North American OTC Healthcare, and International OTC Healthcare. The North American and International OTC Healthcare segments manages the following brands: BC/Goody's, Beano, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Efferdent, Fess, Fleet, Gaviscon, Hydralyte, Luden's, Monistat, Nix, Pedia-Lax, and Summer's Eve. The company was founded in 1996 and is headquartered in Tarrytown, NY.
---
PBH Company Deck
---
PBH Earnings Call
Q2 2024
0:00 / 0:00
---
PBH Stock 12 Month Forecast
Average Price Target
$86.33
▲(5.29% Upside)
Technical Analysis
Best Analysts Covering PBH
1 Year
1 Year Success Rate
10/10 ratings generated profit
1 Year Average Return
+16.65%
reiterated a buy rating 2 months ago
Copying Susan Anderson's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +16.65% per trade.
---